Quality indicators for the prevention of cardiovascular disease in primary care

Jessica Hopkins1, Gina Agarwal, Lisa Dolovich

  • 1McMaster University, Hamilton, ON, Canada. j.hopkins@utoronto.ca

Insights

Collecting cardiovascular disease (CVD) prevention quality indicators in primary care is feasible. While indicator collection doesn't consistently predict short-term outcomes, it significantly increases patient and physician behavioral changes for CVD prevention.

Area of Science:

  • Primary Care Research
  • Cardiovascular Disease Prevention
  • Health Services Research

Background:

  • Quality indicators are crucial for monitoring and improving cardiovascular disease (CVD) prevention in primary care settings.
  • Assessing the feasibility and impact of collecting these indicators is essential for evidence-based practice.
  • Previous research has described several quality indicators for CVD prevention, but their practical application needs further evaluation.

Purpose of the Study:

  • To evaluate the feasibility and usefulness of collecting nine established quality indicators for cardiovascular disease (CVD) prevention within a primary care setting.
  • To determine if the collection of these quality indicators predicts their subsequent collection and influences physician or patient behavior.
  • To assess the association between the collection of quality indicators and behavioral changes aimed at reducing CVD risk.

Main Methods:

  • A retrospective chart audit was conducted in a family health team in Hamilton, Ontario, serving approximately 30,000 patients.
  • A random sample of adult patients (men aged 40-80, women aged 50-80) who underwent complete physical examinations in 2003 were included.
  • Data collection focused on the frequency of quality indicator recording, predictive value for subsequent collection, and associated behavioral changes.

Main Results:

  • Collection rates for most quality indicators exceeded 50% across 237 reviewed patient charts.
  • While specific indicators varied by sex (e.g., obesity checks more frequent in women, blood pressure in men), age significantly predicted repeated cholesterol and blood pressure checks.
  • Collection of most indicators, particularly alcohol consumption, was significantly associated with increased patient or physician behavioral changes for CVD prevention.

Conclusions:

  • The collection of established quality indicators for primary cardiovascular disease prevention in Canadian primary care is feasible.
  • While indicator collection generally does not predict short-term outcomes, it demonstrates a positive association with increased patient and physician behavioral changes.
  • These findings support the integration of quality indicator collection into routine primary care to promote cardiovascular health.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...